Presentation TCT 2024 Patient-Reported Outcomes are a True Measure of TTVI Value Presenter: John Spertus October 30, 2024
Presentation TCT 2024 CV Event Reduction is the Essential Criterion for Implementing New Device Therapies Presenter: Ori Ben-Yehuda October 30, 2024
Presentation TCT 2024 Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate! Presenter: Adam Greenbaum October 30, 2024
Presentation TCT 2024 Re-Do Surgery has Clear Long-Term Advantages and is Preferred! Presenter: Michael Bowdish October 30, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024